Luke Chen, MD, PhD, Glaxo Distinguished Professor, Biological and Biomedical Sciences, Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University. Chen's lab is primarily interested in developing targeted therapy for esophageal squamous cell carcinoma. They are also interested in GERD, Barrett's esophagus and alcohol-associated esophageal diseases.